PATENT CLAIM ANALYSIS

Application Number: 15880801
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "729000"]

Abstract:
A cannabinoid-based pharmaceutical composition for the prevention and treatment of pathogenic viruses (particularly those causing hepatic related conditions such as hepatitis B and C), and most particularly for hepatitis C virus (HCV) infection, having a cannabidiol structure or a pharmaceutically acceptable salt thereof. A method for the prevention and treatment of pathogenic viruses (particularly those causing viral hepatic related conditions such as hepatitis B and C), and most particularly for HCV is also disclosed.

Claim (Index 2):
The method of treating a pathogenic virus according to  claim 1 , wherein said virus is one of as hepatitis A, B, C, D or E.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.88889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14722991', '15789998', '13162160', '15554209', '12141634']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7598148262467692
- 35 USC 102 Novelty (BERT): 0.507435527599678
- Combined Prediction Score: 0.7345768963820601
- Mean Citation Score: 212.47810400000003
- Max Citation Score: 216.57024
- Similarity Product: 130.78316976402286

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test